WELL achieved record annual revenue of $776.1 million for 2023, an increase of 36% compared to the prior year. WELL achieved record quarterly revenues of $231.2 million in Q4-2023, an… Read More
ADPKD is the most common inherited kidney disease, with no treatments currently available that address the underlying cause of disease Vertex to initiate a Phase 1 clinical trial in healthy… Read More
Celebrating 120 years of pioneering healthcare, Getinge reflects on its journey in the industry. With a strong focus on continuous improvement and innovation, the global medtech company stays committed to… Read More
Evonik selected for high-quality Cell Culture Solutions Award celebrates innovation in biopharmaceutical technologies Portfolio expansion and strengthening of application and formulation competence with biosolutions Evonik has been awarded an Asia-Pacific… Read More
OTTAWA, ON — BioTalent Canada is proud to announce the launch of its I.D.E.A.L ScholarshipTM — a groundbreaking initiative designed to promote inclusion, diversity, equity, and accessibility leadership (IDEAL) in science, technology,… Read More
